血管研究与治疗（英文）（Vascular Investigation and Therapy）（OA学术期刊）（国际刊号） 知网目次

期刊简介

《血管研究与治疗》期刊已被查看： 次

更新频次

单位占比

一作占比

投稿指南

1、该刊只有国际刊号。

2、投稿方式：在线投稿。

3、刊内网址：https://www.vitonline.org/

4、投稿系统：

https://www.editorialmanager.com/vit/default.aspx

5、主办单位网址：

http://www.bjhyxglm.cn/newsinfo/726927.html

（北京华炎血管疾病诊疗产业技术创新战略联盟）

6、官网邮箱：editor@vitonline.org（编辑部）

qianliu@sdu.edu.cn

7、官网电话：13146369562

8、出刊日期：季刊，一年出版4期。

2021年10月11日星期一

《血管研究与治疗（英文）》

（Vascular Investigation and Therapy）期刊简介

Vascular Investigation and Therapy 《血管研究与治疗（英文）》于2018年4月创刊，季刊，国际标准连续出版物号p-ISSN 2589-9686，e-ISSN 2589-9481，由国际血管联盟（International Union of Angiology）、欧洲静脉协会（European Venous Forum）和北京华炎血管疾病诊疗产业技术创新战略联盟联合主办、威科集团（Wolters Kluwer）出版。

首都医科大学宣武医院谷涌泉教授和加州大学圣地亚哥医学中心Mahmoud B Malas教授担任期刊共同主编。编委会成员60余人，其中90%来自欧美血管医学机构。

《血管研究与治疗（英文）》作者须知

（Vascular Investigation and Therapy）

【官网信息】

Vascular Investigation and Therapy

Instructions to Authors

The Editorial Process

A manuscript will be reviewed for possible publication with the understanding that it is being submitted to Vascular Investigation and Therapy alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the Vascular Investigation and Therapy readers are also liable to be rejected at this stage itself.

Manuscripts that are found suitable for publication in Vascular Investigation and Therapy are sent to two or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.

Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as ‘Ahead of Print’ immediately on acceptance.

Clinical trial registry

Vascular Investigation and Therapy favors registration of clinical trials and is a signatory to the Statement on publishing clinical trials in Indian biomedical journals. Vascular Investigation and Therapy would publish clinical trials that have been registered with a clinical trial registry that allows free online access to public. Registration in the following trial registers is acceptable: http://www.ctri.nic.in/; https://www.anzctr.org.au/; http://www.clinicaltrials.gov/; http://isrctn.org/; http://www.trialregister.nl/trialreg/index.asp; and http://www.umin.ac.jp/ctr. This is applicable to clinical trials that have begun enrollment of subjects in or after June 2008. Clinical trials that have commenced enrollment of subjects prior to June 2008 would be considered for publication in Vascular Investigation and Therapy only if they have been registered retrospectively with clinical trial registry that allows unhindered online access to public without charging any fees.

Authorship Criteria

Authorship credit should be based only on substantial contributions to each of the three components mentioned below:

Concept and design of study or acquisition of data or analysis and interpretation of data;

Drafting the article or revising it critically for important intellectual content; and

Final approval of the version to be published.

Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors. The journal prescribes a maximum number of authors for manuscripts depending upon the type of manuscript, its scope and number of institutions involved (vide infra). The authors should provide a justification, if the number of authors exceeds these limits.

Contribution Details

Contributors should provide a description of contributions made by each of them towards the manuscript. Description should be divided in following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. Authors' contributions will be printed along with the article. One or more author should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as 'guarantor'.

Conflicts of Interest/ Competing Interests

All authors of articles must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript.

Submission of Manuscripts

All manuscripts must be submitted on-line through the website https://www.editorialmanager.com/vit/default.aspx. First time users will have to register at this site. Registration is free but mandatory. Registered authors can keep track of their articles after logging into the site using their user name and password.

The journal does not charge for submission and processing of the manuscripts.

If you experience any problems, please contact the editorial office by e-mail at editor@vitonline.org

……

更多详情：

https://www.vitonline.org/contributors.asp

上一篇：电子商务与数字经济（英文）（Journal of Electronic Business & Digital Economics）（国际刊号）（不收版面费审稿费）下一篇：整合药学杂志（英文）（Journal of Holistic Integrative Pharmacy）（国际刊号）（2026年3月31日前不收版面费审稿费）